## **Core Concept**
The patient presents with symptoms suggestive of hyperparathyroidism, which is a common feature of Multiple Endocrine Neoplasia Type 1 (MEN 1). MEN 1 is characterized by the occurrence of tumors in multiple endocrine glands, most commonly the parathyroid glands, pancreas, and pituitary gland. Hyperparathyroidism in MEN 1 often leads to hypercalcemia, which can cause nephrolithiasis (urinary stones).

## **Why the Correct Answer is Right**
The correct answer, **Sestamibi scan**, is a reasonable next step in the evaluation of a patient with suspected primary hyperparathyroidism, especially in the context of MEN 1. A sestamibi scan (Technetium-99m-sestamibi) is a nuclear medicine scan that can help localize parathyroid adenomas or hyperplastic glands, which are often the cause of hyperparathyroidism. This is particularly useful in patients with MEN 1, as they may have multiple gland involvement and ectopic glands.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While serum calcium and PTH levels can confirm hyperparathyroidism, repeating these tests does not help in localizing the source of the excess PTH production.
- **Option B:** A CT abdomen might be useful in evaluating for other manifestations of MEN 1 (like pancreatic or pituitary tumors) but is not the best next step for localizing parathyroid disease causing hypercalcemia and nephrolithiasis.
- **Option C:** Ultrasound of the abdomen might be useful for detecting kidney stones but does not directly help in diagnosing or localizing the parathyroid abnormality.

## **Clinical Pearl / High-Yield Fact**
In patients with MEN 1 and hyperparathyroidism, preoperative localization studies like sestamibi scans are crucial for planning surgical intervention, which is often the definitive treatment. Not all patients with MEN 1 hyperparathyroidism require surgery, but when indicated, accurate localization can make surgery more effective.

## **Correct Answer:** B. Sestamibi scan